Transcranial Pulse Stimulation (TPS) as non-invasive brain stimulation in Parkinson’s Disease

Transcranial Pulse Stimulation (TPS) as Non-Invasive Brain Stimulation in Parkinson's Disease. Current state of research and perspectives for patients. The treatment of neurodegenerative diseases poses major challenges for patients, their families, and the medical community. In addition to standard pharmacological therapies, non-invasive, complementary approaches are gaining increasing importance. Transcranial Pulse Stimulation (TPS), which is already successfully utilized as an adjunctive therapy for patients with Alzheimer's disease, is now emerging as a highly promising intervention for Parkinson's disease. New Impulses from Research. After Alzheimer's, Parkinson's disease is the second most common neurodegenerative disorder, affecting over 10 million people worldwide. Beyond classic motor symptoms like resting tremor, muscle rigidity, and slowed movements (bradykinesia), many patients suffer from a heavy burden of non-motor symptoms. These often include sleep disturbances, profound exhaustion and fatigue, and mood fluctuations, all of which drastically reduce quality of life. Recent pioneering studies from the USA (including leading institutions like Spaulding Rehabilitation Hospital and Harvard Medical School) and Italy have now published the first clinical data on the use of TPS in Parkinson's patients. Observed Clinical Effects in Early Studies:. Initial results suggest that TPS may potentially influence both motor and non-motor functional domains:. Motor Symptoms: Measurable improvements in motor function, including reductions in resting tremor., Non-Motor Symptoms: Positive effects on mood, sleep quality, and general well-being., Cognitive Function: Improvements in cognitive performance., Quality of Life: Enhanced overall quality of life. Notably, the US study observed that these positive effects persisted even beyond the actual treatment period. An Emerging Field of Research. These new research findings mark a crucial milestone in the scientific advancement of TPS therapy. While the sample sizes in these early clinical studies are limited, they demonstrate that TPS is a feasible and safe intervention capable of producing behavioral, neurophysiological, and structural effects within the targeted sensorimotor network. Further randomized controlled trials are required and are currently underway to precisely define efficacy, the duration of possible effects, and the most suitable patient groups for this innovative, non-invasive neuromodulation technique. are.